Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Page 1
Long-Term Outcomes in Two-Year Follow-Up after Primary Treatment in Patients with a Prior Venous Thromboembolic Event: A Prospective, Observational, Real-Life Study.
Palareti G, Antonucci E, Bucherini E, Caronna A, Chistolini A, Di Giorgio A, Di Giulio R, Falanga A, Fregoni V, Garzia M, Mastroiacovo D, Marzolo M, Pancani R, Pastori D, Podda GM, Rigoni AM, Ria L, Sivera P, Testa S, Visonà A, Parisi R, Poli D, On Behalf Of The Start Post Vte Investigators. Palareti G, et al. Among authors: mastroiacovo d. J Clin Med. 2024 Feb 27;13(5):1343. doi: 10.3390/jcm13051343. J Clin Med. 2024. PMID: 38592175 Free PMC article.
Venous thromboembolism secondary to hospitalization for COVID-19: patient management and long-term outcomes.
Ageno W, Antonucci E, Poli D, Bucherini E, Chistolini A, Fregoni V, Lerede T, Pancani R, Pedrini S, Pieralli F, Pignatelli P, Pizzini AM, Podda GM, Potere N, Sarti L, Testa S, Visonà A, Palareti G; START 2 Registry VTE study group. Ageno W, et al. Res Pract Thromb Haemost. 2023 May;7(4):100167. doi: 10.1016/j.rpth.2023.100167. Epub 2023 Apr 26. Res Pract Thromb Haemost. 2023. PMID: 37229314 Free PMC article.
BACKGROUND: Venous thromboembolism (VTE) is a complication of COVID-19 in hospitalized patients. Little information is available on long-term outcomes of VTE in this population. OBJECTIVES: We aimed to compare the characteristics, management strategies, and long-term …
BACKGROUND: Venous thromboembolism (VTE) is a complication of COVID-19 in hospitalized patients. Little information is available on long- …
Clinical Presentation and Short- and Long-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE Registry.
Bikdeli B, Caraballo C, Trujillo-Santos J, Galanaud JP, di Micco P, Rosa V, Cusidó GV, Schellong S, Mellado M, Del Valle Morales M, Gavín-Sebastián O, Mazzolai L, Krumholz HM, Monreal M; RIETE Investigators. Bikdeli B, et al. JAMA Cardiol. 2022 Aug 1;7(8):857-865. doi: 10.1001/jamacardio.2022.1988. JAMA Cardiol. 2022. PMID: 35830171 Free PMC article.
IMPORTANCE: Insufficient data exist about the clinical presentation, short-term, and long-term outcomes of patients with isolated distal deep vein thrombosis (IDDVT), that is, thrombosis in infrapopliteal veins without proximal extension or pulmonary embolism (PE). …
IMPORTANCE: Insufficient data exist about the clinical presentation, short-term, and long-term outcomes of patients with isola …
Transient perivascular inflammation of the carotid artery (TIPIC) syndrome.
Micieli E, Voci D, Mumoli N, Mastroiacovo D, Grigorean A, Obadia M, de Champfleur NM, Naggara O, Carsin B, Amor-Sahli M, Cottier JP, Bensoussan J, Auffray-Calvier E, Varoquaux A, Bonneville F, Sadik JC, Kucher N, Lecler A, Barco S. Micieli E, et al. Among authors: mastroiacovo d. Vasa. 2022 Mar;51(2):71-77. doi: 10.1024/0301-1526/a000989. Epub 2022 Feb 8. Vasa. 2022. PMID: 35130715 Free article.
Conclusions: The present analysis elucidates clinical and sonographic characteristics of TIPIC syndrome, indicating the benign nature of this condition. A future international registry will study the long-term course of the disease....
Conclusions: The present analysis elucidates clinical and sonographic characteristics of TIPIC syndrome, indicating the benign nature of thi …
Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-Register.
Palareti G, Legnani C, Antonucci E, Cosmi B, Falanga A, Poli D, Mastroiacovo D, Pengo V, Ageno W, Testa S. Palareti G, et al. Among authors: mastroiacovo d. Ther Adv Drug Saf. 2021 Dec 16;12:20420986211062965. doi: 10.1177/20420986211062965. eCollection 2021. Ther Adv Drug Saf. 2021. PMID: 34987749 Free PMC article.
BACKGROUND: Venous thromboembolism (VTE) is a frequent and serious disease that requires immediate and long-term anticoagulant treatment, which is inevitably associated with a risk of bleeding complications. ...
BACKGROUND: Venous thromboembolism (VTE) is a frequent and serious disease that requires immediate and long-term anticoagulant treatm …
High dose rosuvastatin increases ABCA1 transporter in human atherosclerotic plaques in a cholesterol-independent fashion.
Santovito D, Marcantonio P, Mastroiacovo D, Natarelli L, Mandolini C, De Nardis V, Paganelli C, De Cesare D, Affaitati G, Giamberardino MA, Stellin L, Pinelli M, Weber C, De Blasis G, Occhiuzzi U, Bucci M, Desideri G, Cipollone F. Santovito D, et al. Among authors: mastroiacovo d. Int J Cardiol. 2020 Jan 15;299:249-253. doi: 10.1016/j.ijcard.2019.07.094. Epub 2019 Aug 3. Int J Cardiol. 2020. PMID: 31409515 Clinical Trial.
The mechanism(s) linking treatment with statins and ABCA1/ABCG1 in human atherosclerosis are not fully understood and require further investigation. Therefore, we studied whether short-term treatment with low- or high-dose rosuvastatin may affect ABCA1 and ABCG1 expression …
The mechanism(s) linking treatment with statins and ABCA1/ABCG1 in human atherosclerosis are not fully understood and require further invest …
Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry.
Riera-Mestre A, Mora-Luján JM, Trujillo-Santos J, Del Toro J, Nieto JA, Pedrajas JM, López-Reyes R, Soler S, Ballaz A, Cerdà P, Monreal M; RIETE Investigators. Riera-Mestre A, et al. Orphanet J Rare Dis. 2019 Aug 9;14(1):196. doi: 10.1186/s13023-019-1172-8. Orphanet J Rare Dis. 2019. PMID: 31399146 Free PMC article.
Most PE and DVT patients received low-molecular-weight heparin for initial (71 and 100%, respectively) and long-term therapy (54 and 67%, respectively). During anticoagulation for VTE, the rate of bleeding events (major 2, non-major 6) far outweighed the rate of VTE recurr …
Most PE and DVT patients received low-molecular-weight heparin for initial (71 and 100%, respectively) and long-term therapy (54 and …
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program.
De Felice F, Megiorni F, Pietrantoni I, Tini P, Lessiani G, Mastroiacovo D, Mattana P, Antinozzi C, Di Luigi L, Delle Monache S, Angelucci A, Festuccia C, Fanzani A, Maggio R, Tombolini V, Gravina GL, Marampon F. De Felice F, et al. Among authors: mastroiacovo d. Eur Rev Med Pharmacol Sci. 2019 Mar;23(6):2669-2680. doi: 10.26355/eurrev_201903_17415. Eur Rev Med Pharmacol Sci. 2019. PMID: 30964194 Free article.
OBJECTIVE: Endothelial dysfunction (ED) predisposes to venous thrombosis (VT) and post-thrombotic syndrome (PTS), a long-term VT-related complication. Sulodexide (SDX) is a highly purified glycosaminoglycan with antithrombotic, pro-fibrinolytic and anti-inflammatory activi …
OBJECTIVE: Endothelial dysfunction (ED) predisposes to venous thrombosis (VT) and post-thrombotic syndrome (PTS), a long-term VT-rela …
Characteristics, treatment patterns and outcomes of patients presenting with venous thromboembolic events after knee arthroscopy in the RIETE Registry.
Weinberg I, Giri J, Kolluri R, Arcelus JI, Falgá C, Soler S, Braester A, Bascuñana J, Gutiérrez-Guisado J, Monreal M; RIETE Investigators. Weinberg I, et al. J Thromb Thrombolysis. 2018 Nov;46(4):551-558. doi: 10.1007/s11239-018-1736-9. J Thromb Thrombolysis. 2018. PMID: 30196344 Free article.
While our small sample size precludes drawing firm conclusions, this signal should warrant further research into the optimal treatment duration for these patients, as some patients may be at increased risk for long-term recurrence....
While our small sample size precludes drawing firm conclusions, this signal should warrant further research into the optimal treatment durat …
The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism.
Palareti G, Antonucci E, Mastroiacovo D, Ageno W, Pengo V, Poli D, Testa S, Tosetto A, Prandoni P. Palareti G, et al. Among authors: mastroiacovo d. J Thromb Haemost. 2018 Oct;16(10):1994-2002. doi: 10.1111/jth.14253. Epub 2018 Aug 24. J Thromb Haemost. 2018. PMID: 30059189 Free article.
We assessed the ACCP bleeding risk score in an inception-cohort of patients receiving AC. 53% were categorized at high-risk, but their bleeding rate was low during long-term AC. ACCP score had low predictive value for bleeding. SUMMARY: Background The American College of C …
We assessed the ACCP bleeding risk score in an inception-cohort of patients receiving AC. 53% were categorized at high-risk, but their bleed …
16 results